We strive to offer the highest quality AAVs and adenoviruses to accelerate your scientific discovery.
With 20 years of accumulated expertise, our dedicated PhD scientists understand the complexity of designing viral vectors and have the experience to help you overcome your challenges and accelerate your research. We are currently serving over 1,000 institutions, partnering with the top 20 healthcare companies globally, and have recognized citations in over 5,000 peer-reviewed papers.
Vector Biolabs, the flagship brand for our cell & gene therapy solutions, offers a wide range of viral vector services to suit your research needs. Let us be the partner that empowers your innovation, so we can rewrite the code together.